Efficient B Cell Depletion via Diphtheria Toxin in CD19-Cre/iDTR Mice

Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders

(2011) Klaus Lehmann-Horn et al.   Journal of Neuroinflammation

Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous Nephropathy

(2011) L. H. Beck et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity

(2010) Martin S. Weber et al.   ANNALS OF NEUROLOGY

The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases

(2010) Nichola Cooper et al.   BRITISH JOURNAL OF HAEMATOLOGY

Rituximab for the Treatment of Non-Hodgkinʼs Lymphoma and Chronic Lymphocytic Leukaemia

(2010) Fredrick Hagemeister   DRUGS

B-cell targeted therapies in human autoimmune diseases: an updated perspective

(2010) Michael J. Townsend et al.   IMMUNOLOGICAL REVIEWS

Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis

(2009) Thomas Dörner et al.   AUTOIMMUNITY REVIEWS

First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial

(2008) A. Hagenbeek et al.   BLOOD

Rituximab: Beyond Simple B Cell Depletion

(2008) A. Kessel et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

New tools to study the role of B cells in cytomegalovirus infections

(2008) Ari Waisman et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE